John Thistlewood Davenport (1817–1901) was an English pharmacist and businessman.[1] He was the founder of J. T. Davenport & Sons, a pharmaceuticals company based in Great Russell Street, London which bought the patent for Dr. John Collis Browne's 'chlorodyne'[citation needed] and sold the famous drug for ailments including headache, stomachache, insomnia, and cholera. Davenport served as Vice-President of the Royal Pharmaceutical Society of Great Britain (formerly the Pharmaceutical Society of Great Britain) from 1853–55 and as its President, 1855-56. An obituary for him in the Society's Pharmaceutical Journal gave this credit to him: “the first official recognition of the Society in connection with the British Pharmacopoeia may be said to date from the time of Mr. Davenport’s presidency.”[2]
- ^ Deaths, The Chemist and Druggist, p. 12 (January 2, 1902)
- ^ "Obituary: John Thistlewood Davenport". Pharmaceutical Journal. LXVIII (Fourth Series, Vol XIV) (Jan-June 1902). Retrieved 14 May 2018.